Quantcast

Latest Alere Inc. Stories

2014-10-28 08:34:31

WALTHAM, Mass., Oct. 28, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today announced its financial results for the quarter ended September 30, 2014. Namal Nawana, Chief Executive Officer and President of Alere said, "We made great progress during the third quarter to reset our strategic direction to focus on our strengths as the Global Leader in Rapid Diagnostics. Doing so has allowed us to begin to execute a...

2014-10-28 08:34:28

WALTHAM, Mass., Oct. 28, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that Namal Nawana has been named Chief Executive Officer, President, and a Member of the Board of Directors of Alere. Nawana joined Alere in December 2012 as Chief Operating Officer and was appointed Interim Chief Executive Officer and President of Alere in July 2014. "After a thorough search process, I am very pleased to announce that the Board of...

2014-10-21 08:33:32

WALTHAM, Mass., Oct. 21, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that it will release its third quarter 2014 earnings on Tuesday, October 28, 2014. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends....

2014-10-02 08:29:52

First rapid test to distinguish between pathogenic and non-pathogenic species WALTHAM, Mass., Oct. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today that the new E. HISTOLYTICA QUIK CHEK(TM) test, which identifies the Entamoeba histolytica parasite, has received CE Mark for sale in international markets outside of the United States. The test is developed and manufactured by TECHLAB(®) Inc. Entamoeba histolytica is an intestinal...

2014-10-01 08:31:40

The U.S. Department of Health and Human Services will fund up to $12.9 million for the development of Alere's next-generation POC molecular influenza test WALTHAM, Mass., Oct. 1, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostics, today announced that it has entered into a contract with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop diagnostic...

2014-09-23 12:30:51

100,000 HIV/Syphilis Duo Rapid Tests Donated to African First Ladies to Launch OAFLA's Push to Eliminate Mother-to-Child Transmission of HIV and Syphilis in Their Countries NEW YORK, Sept. 23, 2014 /PRNewswire/ -- Representatives from the Organisation of African First Ladies Against HIV/AIDS, UNAIDS, the International Planned Parenthood Federation (IPPF) and Alere (NYSE: ALR), the world leader in rapid HIV screening and diagnostics products, today called for intensified efforts to...

2014-09-19 08:26:21

WALTHAM, Mass., Sept. 19, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, issued the following statement today in support of President Barack Obama's Executive Order Combating Antibiotic-Resistant Bacteria. "As the global leader in rapid diagnostics for infectious disease, we commend the President for establishing a national strategy to address the serious threat of antibiotic resistance. We look forward to continuing to work with the Administration...

2014-09-15 20:22:03

WALTHAM, Mass., Sept. 15, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company" or "Alere"), a global leader in infectious disease, toxicology, cardiology and diabetes products and services, today confirmed that a group of former executives, led by former CEO Ron Zwanziger, filed a Schedule 13D with the Securities and Exchange Commission and subsequently sent a letter to Gregg J. Powers, Chairman of the Board, requesting one month of due diligence in an effort to secure financing...

2014-09-15 08:29:19

DUBLIN, Sept. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Cardiac POC Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular...

2014-09-02 20:24:43

WALTHAM, Mass., Sept. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on October 15, 2014 to holders of record of Series B stock at the close of business on October 1, 2014. Such payment will cover the amount of all dividends accrued from July 1, 2014 through...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.